Dr. Scott W. Biggins is Professor of Medicine & UPMC Endowed Chair for Patient Centered Care, Chief of Hepatology, Director of UPMC Liver Care, Medical Director of Liver Transplant and Co-Director of Clinical Research at the University of Pittsburgh Starzl Transplant Institute. Dr. Biggins is a nationally recognized clinician and researcher in the field of Hepatology. He received his undergraduate degree in chemical engineering (bioengineering option) from UCLA and his medical degree from USC.

Sumera I. Ilyas, M.D, is an Associate Professor of Medicine at the Mayo Clinic College of Medicine and Science. She is a physician-scientist who underwent training in internal medicine at the University of Pittsburgh Medical Center and subsequently completed Gastroenterology and Transplant Hepatology fellowships at the Mayo Clinic, Rochester. Her academic focus is hepatobiliary neoplasia. She is the director of the Mayo Clinic Hepatobiliary Neoplasia Clinic and Transplant Oncology Clinic.

Daniela Sia is an Associate Professor in the Division of Liver Diseases, Department of Medicine, at Icahn School of Medicine at Mount Sinai (ISMMS). Her current research focuses on generating a deep knowledge of the molecular mechanisms driving biliary tract cancers with the ultimate goal of identifying novel therapeutic targets.

Dr. Tinsay Woreta is an Associate Professor of Medicine at the Johns Hopkins University School of Medicine. She completed her medical and MPH degrees as well as Internal Medicine residency and Gastroenterology and Transplant Hepatology fellowship at Johns Hopkins. Her clinical and research interests are focused on the diagnosis and management of patients with metabolic dysfunction-associated steatotic liver disease.

Nicole Kim, MD, MPH is an Assistant Professor of Medicine within the Division of Gastroenterology and Hepatology at the University of Washington. Dr. Kim has a research interest in improving clinical outcomes in liver disease and promoting the early detection of liver cancer through timely receipt of screening.

Dr. Justin Boike is an Associate Professor of Medicine at Northwestern Memorial Hospital and is a practicing Hepatologist and Transplant Hepatologist. He cares for patients with a wide range of liver diseases including cirrhosis and liver transplant. His clinical and research interest is in the management of complex portal hypertension issues such as chronic portal vein thrombosis (PVT), non-invasive assessment of portal hypertension, non-cirrhotic portal hypertension and the utilization and outcomes of TIPS.

Dr. Wegermann is an Assistant Professor of Medicine at Duke University. She completed her residency, chief residency, GI and transplant hepatology fellowships at Duke. Her research interest is MASLD in persons with HIV. She is currently funded by an ACG Junior Faculty Development Award.

I am a transplant hepatologist, clinical researcher, and Assistant Professor of Medicine at the University of North Carolina (UNC). I practice within the UNC Multidisciplinary HCC Clinic. The overall goal of my clinical work and research is to improve outcomes among patients with liver disease and hepatocellular carcinoma (HCC) by identifying risk factors for liver disease and HCC development, optimizing earlier disease detection and designing interventions to proactively address symptoms and liver-related decompensation related to HCC treatments.

Barbara Testoni is a research scientist and team leader at The Lyon Hepatology Institute EVEREST, Lyon, France. She obtained her PhD in Genetics and Molecular Biology at the University of Milan, working on eukaryotic transcriptional regulation in the setting of skin development. Then, she moved to the University of Rome "La Sapienza", where she began to work on liver disease and type-I interferon signaling.